FDA label
What is Movantik used for?
Movantik contains naloxegol. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “MOVANTIK ® is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Movantik?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Movantik, tablet, film coated
Indications and Usage, quoted from the label by Averitas Pharma, Inc. (NDA204760). Cross-references to other label sections are left out.
MOVANTIK ® is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.
Source: DailyMed label, set id 28596788-b73f-4247-85fc-3105f51fff5a, version 5, effective September 1, 2026. NDC 82625-8801, one of 3 listings for this product.
Questions
What is Movantik used for?
The FDA label says: “MOVANTIK ® is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.”
What drug class is Movantik?
FDA lists naloxegol in the Opioid Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.